[1] Agusti A, Celli BR, Criner GJ, et al.Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary[J]. Am J Respir Crit Care Med, 2023, 207(7): 819-837. [2] Wang C, Xu J, Yang L, et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J]. Lancet, 2018, 391(10131): 1706-1717. [3] Agustí A, Melén E, DeMeo DL, et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan[J]. Lancet Respir Med, 2022, 10(5): 512-524. [4] Wang J, Cao B.Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistance[J]. Curr Opin Pulm Med, 2019, 25(2): 512-524. [5] 中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组,等. 中国肺动脉高压诊断与治疗指南(2021版)[J]. 中华医学杂志,2021,101(1):11-51. [6] Wang S, Yang L, Ci B, et al.Development and Validation of a Nomogram Prognostic Model for SCLC Patients[J]. J Thorac Oncol, 2018, 13(9): 1338-1348. [7] Deng X, Hou H, Wang X, et al.Development and validation of a nomogram to better predict hypertension based on a 10-year retrospective cohort study in China[J]. ELife, 2021, 10: e66419. [8] Wu J, Qiu J, Jiang W, et al.Development and validation of a nomogram predicting the probability of type a aortic dissection at a diameter below 55 mm: A retrospective cohort study[J]. Int J Surg, 2018, 60: 266-272. [9] Humbert M, Kovaccs G, Hoeper MM, et al.2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Respir J, 2023, 61(1): 2200879. [10] Polverino F, Celli B, Owen C.COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series)[J]. Pulm Circ, 2018, 8(1): 2045894018758528. [11] Labaki WW, Rosenberg SR. Chronic Obstructive Pulmonary Disease[J]. Ann Intern Med, 2020, 173(3): ITC17-ITC32. [12] Marco E, Sánchez-Rodríguez D, Dávalos-Yerovi VN, et al.Malnutrition according to ESPEN consensus predicts hospitalizations and long-term mortality in rehabilitation patients with stable chronic obstructive pulmonary disease[J]. Clin Nutr, 2019, 38(5): 2180-2186. [13] Rong YD, Bian AL, Hu HY, et al.Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10[J]. BMC Geriatr, 2018, 18(1): 308. [14] Kor CT, Li YR, Lin PR, et al.Explainable Machine Learning Model for Predicting First-Time Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease[J]. J Pers Med, 2022, 12(2): 228. [15] Zheng Q, Zhang B, Lu N, et al.Diagnostic values of serum BNP, PTX3, and VEGF in acute pulmonary embolism complicated by pulmonary artery hypertension and their correlations with severity of pulmonary artery hypertension[J]. Immun Inflamm Dis, 2023, 11(9): e986. [16] Chin KM, Rubin LJ, Channick R, et al.Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension[J]. Circulation, 2019, 139(21): 2440-2450. [17] 姜锋,孙树东,庞桂芬,等. 不同部位下肢深静脉血栓与急性肺栓塞并发肺动脉高压严重程度的关系[J]. 血管与腔内血管外科杂志,2022,8(4):447-452. [18] 吴启建,张二龙,孙滨达,等. TLR9-JNK信号通路调控缺氧诱导大鼠肺动脉平滑肌细胞增殖[J]. 第三军医大学学报,2021,43(21):2350-2357. [19] 涂友慧,胡先纬,尤青海. 慢性阻塞性肺疾病急性加重期合并肺动脉高压的高危因素分析[J]. 临床肺科杂志,2023,28(12):1867-1871. [20] Zouyou L, Shiota S, Morio Y, et al.Borderline pulmonary hypertension associated with chronic hypercapnia in chronic pulmonary disease[J]. Respir Physiol Neurobiol, 2019, 262: 20-25. |